Balanol

Balanol

SCHEMBL62129

O=C(N[C@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCB P05771 20/20 1.00
PRKCA P17252 20/20 1.00
PRKCE Q02156 19/20 1.00
PRKCG P05129 17/20 1.00
PRKCH P24723 17/20 1.00
PRKCD Q05655 17/20 1.00
PRKACA P17612 14/20 1.00
PRKACG P22612 10/20 1.00
PRKACB P22694 10/20 1.00
PRKCZ Q05513 9/20 1.00
PRKD3 O94806 3/20 1.00
PRKCI P41743 3/20 1.00
PRKCQ Q04759 3/20 1.00
PRKD1 Q15139 3/20 1.00
GRK2 P25098 1/20 1.00
GRK4 P32298 1/20 1.00
GRK5 P34947 1/20 1.00
GRK3 P35626 1/20 1.00
GRK6 P43250 1/20 1.00
PRKG1 Q13976 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Balanol SCHEMBL62128 1.00 PRKCB (1.00) PRKCBPRKCAPRKCEPRKCGPRKCH
Balanol SCHEMBL12012990 1.00 PRKCB (1.00) PRKCBPRKCAPRKCEPRKCGPRKCH
Balanol SCHEMBL8666687 0.99 PRKCB (0.98) PRKCBPRKCAPRKCEPRKCGPRKCH
Balanol SCHEMBL9196065 0.97 PRKCB (0.94) PRKCBPRKCAPRKCEPRKCGPRKCH
Balanol SCHEMBL9198287 0.95 PRKCB (0.91) PRKCBPRKCAPRKCEPRKCGPRKCH
Balanol SCHEMBL9198347 0.95 PRKCB (0.91) PRKCBPRKCAPRKCEPRKCGPRKCH
Balanol SCHEMBL9393094 0.95 PRKCB (0.91) PRKCBPRKCAPRKCEPRKCGPRKCH
SCHEMBL14515466 0.94 PRKCB (1.00) PRKCBPRKCAPRKCEPRKCGPRKCH
SCHEMBL17251291 0.93 PRKCB (0.87) PRKCBPRKCAPRKCEPRKCGPRKCH
SCHEMBL9396551 0.92 PRKCB (0.86) PRKCBPRKCAPRKCEPRKCGPRKCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 8000 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026090557-A1 SYSTEMS AND METHODS FOR PROCESSING ISM AND MCAS CLINICAL TRIAL DATA TELIOS PHARMA INC. (US) 2026-04-30 WO claimed
US-20260116861-A1 ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) 2026-04-30 US claimed
US-12522572-B2 Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) 2026-01-13 US claimed
EP-4662211-A1 G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2) DEGRADATION COMPOUNDS AND USE THEREOF Nanjing Huanbo Biotechnology Co., Ltd. (CN) 2025-12-17 EP claimed
US-20240343697-A1 ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) 2024-10-17 US claimed
WO-2024165075-A1 G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2) DEGRADATION COMPOUNDS AND USE THEREOF NANJING HUANBO BIOTECHNOLOGY CO., LTD. (CN) 2024-08-15 WO claimed
US-11345956-B2 Methods and compositions related to prostate cancer therapeutics THE JOHNS HOPKINS UNIVERSITY (US) 2022-05-31 US claimed
CN-114231574-A Culture medium and method for producing protein kinase C inhibitor balanol 浙江大学 2022-03-25 CN claimed
US-11207289-B2 Use of benzofuran lignans to induce IL-25 expression and suppress mammary tumor metastasis ACADEMIA SINICA (TW) 2021-12-28 US claimed
US-10953073-B2 XTEN conjugate compositions and methods of making same AMUNIX PHARMACEUTICALS, INC. (US) 2021-03-23 US claimed
EP-1351678-A2 TREATMENT FOR INHIBITING NEOPLASTIC LESIONS USING INCENSOLE AND/OR FURANOGERMACRENS Shanahan-Prendergast, Elizabeth (IE) 2003-10-15 EP claimed
WO-2001035899-A9 INHIBITORS OF HELICOBACTER PYLORI INDUCED GASTROINTESTINAL DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-09-19 WO claimed
EP-1229925-A2 INHIBITORS OF HELICOBACTER PYLORI INDUCED GASTROINTESTINAL DISEASES Axxima Pharmaceuticals Aktiengesellschaft (DE) 2002-08-14 EP claimed
WO-2002053138-A2 TREATMENT FOR INHIBITING NEOPLASTIC LESIONS USING INCENSOLE AND/OR FURANOGERMACRENS SHANAHAN-PRENDERGAST ELISABETH (IE) 2002-07-11 WO claimed
WO-2001035899-A2 INHIBITORS OF HELICOBACTER PYLORI INDUCED GASTROINTESTINAL DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2001-05-25 WO claimed
EP-0783292-A1 INHIBITION OF HAIR GROWTH HANDELMAN, Joseph H. (US) 1997-07-16 EP claimed
US-5554608-A INHIBITOR OF PROTEIN KINASE C GILLETTE COMPANY, THE, A DELAWARE CORPORATION 1996-09-10 US claimed
WO-1996009806-A2 INHIBITION OF HAIR GROWTH HANDELMAN, JOSEPH, H. (US) 1996-04-04 WO claimed
EP-0687249-A1 BALANOIDS ELI LILLY AND COMPANY (US) 1995-12-20 EP claimed
WO-1994020062-A2 BALANOIDS AS PROTEIN KINASE C INHIBITORS ELI LILLY AND COMPANY (US) 1994-09-15 WO claimed